Sino Biopharmaceutical Says CDE Accepts NDA For Ropivacaine Hydrochloride Solution

Sino Biopharmaceutical Ltd HKEX:1177:

• CHINA'S CDE ACCEPTS NEW DRUG APPLICATION FOR ROPIVACAINE HYDROCHLORIDE SUSTAINED-RELEASE SOLUTION